Skip to NavigationSkip to content

India hits back at claims they are leading source of counterfeit drugs

Published on 29/04/19 at 10:04am

India has rejected claims that they, along with China, are the chief source of counterfeit medicines around the world.

In response to the allegations, the Indian health secretary said the accusations present an attack on “low cost generics and the thriving Indian drug manufacturing industry.”

The dispute comes after the US chose to keep India on its “priority watch list” of countries failing to uphold intellectual property (IP).

The United States Trade Representative’s (USTR) ‘Special 301 Report,’ claimed India and China were the leading sources of ‘counterfeit drugs’.

Meanwhile India were declared to be “one of the world’s most challenging major economies,” when it comes to IP.

“While it may not be possible to determine an exact figure, studies have suggested that up to 20% of drugs sold in the Indian market are counterfeit and could represent a serious threat to patient health and safety,” the USTR report said.

Indian Health Secretary Preeti Sudan, responded in stating: “We strongly disagree with the observations made by USTR. We do not know the genesis and methodology of their findings. Instead we view this as opposition to low cost generics and the thriving Indian drug manufacturing industry which is the ‘Pharmacy of the World’”

Medical NGO, Médecins sans frontières (MSF), commented: “At a time when medicine prices are soaring, the report undermines the efforts seeking to make medicines more affordable domestically. USTR’s push for more protection and enforcement of IP policies would keep medicine prices high globally and place lifesaving treatments out of reach for longer in developing countries.”

India supplies 40% of generics to the US market and 25% of all medicines in the UK.The country’s pharmaceutical market was worth $33 billion in 2017 and is set to reach $55 billion next year.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches